The Supreme Court considered the question, “Can human genes be patented?” when it heard oral arguments in the case of Association for Molecular Pathology v. Myriad Genetics, Inc. Case materials, legal commentary, and reports of the oral arguments are available on www.scotusblog.com. The Washington Post reported after the oral arguments, “The Supreme Court on Monday seemed skeptical that a human gene can be patented but also worried about what a decision to bar such patents would mean for private scientific inquiry and research.”
Make An Impact
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
- Get Involved
- COVID-19 Resources for Cancer Survivors
- Survivorship Checklist
- Cancer Survival Toolbox
- Cancer Convos Podcast
- Taking Charge of Your Care
- Care Planning for Cancer Survivors
- Tools For Care Providers
- Order Our Resources
- Contact Us
Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.